- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 31.16M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $8.93M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.72M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $27.13M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $18.03M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $27.19M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $18.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.29M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.64M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 190.28K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.13M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $12.07M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$42.19 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$42.19 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.16M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.5M |